Dr. Timothy Schulz-Utermoehl
Fähigkeiten und Kenntnisse
Werdegang
Berufserfahrung von Timothy Schulz-Utermoehl
- Current 6 years and 8 months, since Oct 2019
Chief Operating Officer
Round Earth Therapeutics
- Current 6 years and 9 months, since Sep 2019
Chief Operating Officer
Pandeia Therapeutics Limited
- Current 6 years and 9 months, since Sep 2019
Cofounder and NED
Pencil Biosciences Ltd
- Current 8 years and 3 months, since Mar 2018
Co-founder and NED
Pedanius Therapeutics Limited
- Current 9 years and 6 months, since Dec 2016
Co-founder and NED
Belfry Therapeutics Limited
- 4 years and 4 months, Sep 2016 - Dec 2020
Vice President, Preclinical Development
Chronos Therapeutics Limited
- 5 years and 2 months, Dec 2014 - Jan 2020
Director, Head of DMPK
Sygnature Discovery Limited
- 2 years and 11 months, Apr 2011 - Feb 2014
Director (DMPK), Exploratory Projects
Shire Pharmaceuticals
- 3 months, Feb 2011 - Apr 2011
Acting ADME Section Head, Oncology iMed DMPK
AstraZeneca
- 5 years, Mar 2006 - Feb 2011
Group Manager, In Vitro ADME, Clinical Pharmacology & DMPK
AstraZeneca
Leadership • Successfully provided leadership to a team of up to 11 graduates and postgraduates • Chaired the in vitro PK science network for global CPD • Attended AZ High Impact Leadership Skills (HILS), Constructive Conversations, Employee Relations and Finance for Managers workshops • Led the execution and delivery of the ADME group’s project resource forecasting figures for the quarterly Business Updates • Led a global group in the review of the in vitro ADME competencies and capabilities of CROs
- 2 years and 5 months, Sep 2003 - Jan 2006
Senior Research Scientist
Merck Sharp & Dohme
Supported the delivery of DMPK packages for pre-clinical candidates. This included analysing, interpreting and reporting in vitro and in vivo metabolism, in vivo pharmacokinetic and radiolabeled animal ADME studies. In addition, as site member of Merck’s DMPK global scientific task force on drug transporters, CYP450 inhibition and bioactivation, collaborated with site and global colleagues to establish global scientific strategies for the DMPK organisation
- 1 year and 11 months, Oct 2001 - Aug 2003
Group Leader, in vitro metabolism and transporters
Merck Sharp & Dohme
Provided expert leadership in the application of drug metabolism and transporter assays within Discovery DMPK. Led a team of two postgraduates.
Postdoctoral Research Scientist within DMPK Discovery & Preclinical Development
Ausbildung von Timothy Schulz-Utermoehl
- 1996 - 1999
Biochemistry
Imperial College of the University of London
- 1994 - 1995
Toxicology
Royal Postgraduate Medical School of the University of London
- 1991 - 1994
Pharmacology/Physiology
University of Leeds
Biochemistry
- 1989 - 1991
United World College of South East Asia
Sprachen
English
C2 (Verhandlungssicher / Muttersprachlich)
German
C1 (Fließend)
XING Mitglieder mit ähnlichen Profilangaben
XING – Das Jobs-Netzwerk
Über eine Million Jobs
Entdecke mit XING genau den Job, der wirklich zu Dir passt.
Persönliche Job-Angebote
Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.
21 Mio. Mitglieder
Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.
Kostenlos profitieren
Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.